EUVIMEDEUVIMED entdecken
Crossref

Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease

Joshua G. Rivenbark, Samuel R. Wilson

The Hematologist · 01.05.2026 · 23 (3)

DOI: 10.1182/hem.v23.3.202637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Hematologist, online erschienen am 17.04.2026. Verfasst von Joshua G. Rivenbark und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rivenbark, J. G., & Wilson, S. R. (2026). Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease. The Hematologist, 23(3). https://doi.org/10.1182/hem.v23.3.202637

Vancouver

Rivenbark JG, Wilson SR. Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease. The Hematologist. 2026;23(3). doi:10.1182/hem.v23.3.202637

BibTeX
@article{Rivenbark2026,
  author = {Rivenbark, Joshua G. and Wilson, Samuel R.},
  title = {Rilzabrutinib: An Anti-inflammatory Therapy for Vaso-Occlusive Pain in Sickle Cell Disease},
  journal = {The Hematologist},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1182/hem.v23.3.202637}
}
Kostenlos starten →